For more information on Parkinson’s research please visit Parkinson’s Europe website.
Researchers develop light-activated Parkinson’s drug
Author: Simge Eva DoganPublished: 18 July 2018
Prep: Cook: Serves:
A new light-activated drug for treating Parkinson’s has been developed by a research team led by the University of Barcelona, Spain.
The drug – named MRS7145 – is placed within a brain implant and then activated by shining a light on it.
The effect of the newly developed drug was tested on live mice to see if it could improve their motor function. The results – published in ‘Journal of Controlled Release’ – showed that MRS7145 reduced tremors and seizures and improved the mice’s ability to walk.
Professor Francisco Ciruela, researcher at the Faculty of Medicine and Health Sciences of the University of Barcelona, Spain, said he envisaged the drug being administered by smart phones, with “the doctor (controlling) in a precise manner the release of the most efficient dose of the active drug in the place of action”.
Share this story
6 world-class wildlife shots by a photographer with Parkinson’s
Wildlife photographer with Parkinson’s shares his favourite shotsREAD MORE
Bill Bucklew on walking 2,500 miles for Parkinson’s
Bill Bucklew tells us why he's not afraid of failureREAD MORE
10 shocking facts that show what it’s like to be a carer
Highlighting the issues faced by carers throughout EuropeREAD MORE